- Effect of coadministration of ketoconazole, a strong CYP3A4 inhibitor, on pharmacokinetics and tolerability of motesanib diphosphate (AMG 706) in patients with advanced solid tumors. Lorusso, P., Heath, E.I., McGreivy, J., Sun, Y.N., Melara, R., Yan, L., Malburg, L., Ingram, M., Wiezorek, J., Chen, L., Pilat, M.J. Invest. New. Drugs (2008)